ClinicalTrials.gg
Drug

Zimberelimab clinical trials

Also written AB122 and GLS-010.

studies test it
51
open now
23
in phase 3
6
first study started
2017

How each study uses zimberelimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the zimberelimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zimberelimab
32
Zimberelimab (AB122)
2
Full-human anti-pd-1 monoclonal antibodies
2

Development codes

AB122
19
GLS-010
9
GS-0122
2
WBP-3055
1

Other names

Anti-PD-1 Monoclonal Antibody GLS-010
1

Studies by the year they started

51 studies that test it; most in 2023 (17)

Studies that test zimberelimab, by start year
YearStudies
20171
20183
20193
20201
20215
20227
202317
20245
20253
20266

Who runs them

Industry 20 · Other 31

Guangzhou Gloria Biosciences Co., Ltd. (7) · Arcus Biosciences, Inc. (6) · Gilead Sciences (4) · Sun Yat-sen University (3) · Hospices Civils de Lyon (2) · Taiho Pharmaceutical Co., Ltd. (2) · Washington University School of Medicine (1) · Memorial Sloan Kettering Cancer Center (1)

Often tested with

Tested in the same studies.

Domvanalimab (14) · AB928 (9) · Sacituzumab govitecan (5) · Quemliclustat (3) · Brivestobart (2) · FOLFOX-4 Regimen (1) · Carboplatin (1) · Pemetrexed (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 13

Studies that test zimberelimab.

Studies

Open first, then newest update. How each study uses zimberelimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 51

See all 51 studies that test zimberelimab →

Given beside what is tested · 19 — zimberelimab is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with zimberelimab

Codes

What other systems call zimberelimab · ClinicalTrials.gg INT001731

  • MeSH (NLM) C000719848zimberelimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) ZBL7O904ILZIMBERELIMABConfirmed FDA, NLM
  • NCI Thesaurus C159549ZimberelimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.